Visit our Expo - Redox and Inflammation signaling 2012

Table of content
PREFACE ......................................................................................................................................................................5
ACKNOWLEDGMENTS ...........................................................................................................................................7
GENERAL INFORMATION .....................................................................................................................................8
EXHIBITION ..............................................................................................................................................................11
SCIENTIFIC PROGRAM ........................................................................................................................................14
WEDNESDAY JANUARY 25TH, 2006.......................................................................................................................14
THURSDAY JANUARY 26TH, 2006 (EARLY MORNING SESSION) .........................................................................15
THURSDAY JANUARY 26TH, 2006 (MORNING SESSION)......................................................................................15
THURSDAY JANUARY 26TH, 2006 (EVENING SESSION) .......................................................................................17
FRIDAY JANUARY 27TH, 2006 (EARLY MORNING SESSION) ...............................................................................18
FRIDAY JANUARY 27TH, 2006 (MORNING SESSION) ...........................................................................................18
FRIDAY JANUARY 27TH, 2006 (EVENING SESSION).............................................................................................20
SATURDAY JANUARY 28TH, 2006 (EARLY MORNING SESSION)..........................................................................21
SATURDAY JANUARY 28TH, 2006 (MORNING SESSION)......................................................................................21
ORAL PRESENTATIONS........................................................................................................................................23
WORKSHOP PRESENTATIONS.........................................................................................................................107
POSTER PRESENTATIONS .................................................................................................................................117
SESSION I. PROTEIN DOMAINS ............................................................................................................................118
SESSION II. RECEPTOR SIGNALING AND G PROTEINS.......................................................................................127
SESSION III. PROTEIN KINASE CASCADES AS THERAPEUTIC TARGETS ...........................................................183
SESSION IV. PROTEIN KINASE INHIBITORS: INSIGHTS INTO DRUG DESIGN FROM STRUCTURE....................257
SESSION V. PHOSPHATASES AS KEY CELL SIGNALING INTERMEDIATES.........................................................266
SESSION VI. PROTEASOME DEGRADATION PATHWAYS ....................................................................................276
SESSION VII. STEM CELL SPECIFIC CELL SIGNALING MECHANISMS...............................................................281
SESSION VIII. INFLAMMATION SPECIFIC SIGNALING .......................................................................................284
SESSION IX. NOVEL COMPOUNDS TARGETING INFLAMMATORY SIGNALING PATHWAYS.............................324
SESSION X : CELL DEATH IN CANCER .................................................................................................................333
SESSION XI : CELL DEATH AND CARDIOVASCULAR DISEASES.........................................................................445
SESSION XII : CELL DEATH AND NEURODEGENERATIVE DISEASES ................................................................458
SESSION XIII : CELL SIGNALING PATHWAYS LEADING TO REGULATED CHROMATIN MODIFICATIONS .....488
SESSION XIV : TRANSCRIPTIONAL AND TRANSLATIONAL CONTROL..............................................................503
SESSION XV : REACTIVE OXYGEN SPECIES AND CELL SIGNALING..................................................................585
SESSION XVI : CHEMOPREVENTIVE AGENTS ....................................................................................................592
SESSION XVII : CELL SIGNALING IN HEALTH AND DISEASE ............................................................................607
LIST OF PARTICIPANTS .....................................................................................................................................672
- 3 -